FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W137668043> ?p ?o ?g. }

• W137668043 endingPage "91" @default.
• W137668043 startingPage "77" @default.
• W137668043 abstract "With widespread resistance to pentavalent antimonial in the endemic eastern terai belt of Nepal and Bihar, India, Amphotericin B deoxycholate is now the first-line antileishmanial drug for the treatment of visceral leishmaniasis (VL). However, universal occurrence of infusion-related fever and rigors with amphotericin B (AmB), occasional serious life-threatening toxicities like cardiotoxicity, anaphylaxis, hypokalemia, and nephrotoxicity are major barriers to its use in areas with limited medical facilities. Liposomal amphotericins, however, are devoid of adverse effects, high cost makes it unaffordable. We had formulated nanoparticles (10-20 nm) from amphotericin B deoxycholate (1-2 μm) applying high pressure (150 atm) milling homogenization in argon atmosphere and tested its ex vivo efficacy in Leishmania infected J774A cell line and peritoneal macrophage. The ex vivo ED50 for intracellular amastigotes in peritoneal macrophage by nano-amphotericin was 0.0027 ± 0.001 μg/mL which was significantly less (p = 0.0029) than the required dose of amphotericin B (0.0426 ± 0.003 μg/mL). Similarly, in J774A cell line, 50 % of intracellular amastigotes were cleared by 0.0038 ± 0.001 μg/mL of nano-amphotericin while the dose was a bit more for AmB (0.0196 ± 0.001 μg/mL) illustrating the significant difference (p value, 0.0122). The nanoformulation has also shown high efficacy (ED50, 0.0028-0.0035 μg/mL) in inhibition of infected macrophage count. The new formulation accumulated to spleen, the targeted organ, 7 days after inoculation of drug to the infected hamster as traced in vivo by TEM convincing it as potential drug. Given a favorable safety profile and very low cost of production contemplated, it may prove to be a feasible alternative for conventional amphotericin B." @default.
• W137668043 created "2016-06-24" @default.
• W137668043 creator A5005151809 @default.
• W137668043 creator A5019658053 @default.
• W137668043 creator A5029573982 @default.
• W137668043 creator A5037014831 @default.
• W137668043 creator A5037204665 @default.
• W137668043 creator A5082763515 @default.
• W137668043 creator A5083008310 @default.
• W137668043 creator A5089922443 @default.
• W137668043 date "2014-01-01" @default.
• W137668043 modified "2023-10-09" @default.
• W137668043 title "Nanonization Increases the Antileishmanial Efficacy of Amphotericin B: An Ex Vivo Approach" @default.
• W137668043 cites W1264540065 @default.
• W137668043 cites W1548019309 @default.
• W137668043 cites W1594437063 @default.
• W137668043 cites W1988564937 @default.
• W137668043 cites W2012311957 @default.
• W137668043 cites W2014476907 @default.
• W137668043 cites W2025822586 @default.
• W137668043 cites W2030695924 @default.
• W137668043 cites W2056211275 @default.
• W137668043 cites W2056211711 @default.
• W137668043 cites W2060240525 @default.
• W137668043 cites W2066954635 @default.
• W137668043 cites W2082293404 @default.
• W137668043 cites W2114408384 @default.
• W137668043 cites W2141583445 @default.
• W137668043 cites W2145947441 @default.
• W137668043 cites W2168946125 @default.
• W137668043 cites W2170542143 @default.
• W137668043 doi "https://doi.org/10.1007/978-81-322-1774-9_7" @default.
• W137668043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24595612" @default.
• W137668043 hasPublicationYear "2014" @default.
• W137668043 type Work @default.
• W137668043 sameAs 137668043 @default.
• W137668043 citedByCount "8" @default.
• W137668043 countsByYear W1376680432015 @default.
• W137668043 countsByYear W1376680432017 @default.
• W137668043 countsByYear W1376680432018 @default.
• W137668043 countsByYear W1376680432019 @default.
• W137668043 countsByYear W1376680432020 @default.
• W137668043 countsByYear W1376680432021 @default.
• W137668043 crossrefType "book-chapter" @default.
• W137668043 hasAuthorship W137668043A5005151809 @default.
• W137668043 hasAuthorship W137668043A5019658053 @default.
• W137668043 hasAuthorship W137668043A5029573982 @default.
• W137668043 hasAuthorship W137668043A5037014831 @default.
• W137668043 hasAuthorship W137668043A5037204665 @default.
• W137668043 hasAuthorship W137668043A5082763515 @default.
• W137668043 hasAuthorship W137668043A5083008310 @default.
• W137668043 hasAuthorship W137668043A5089922443 @default.
• W137668043 hasConcept C136764020 @default.
• W137668043 hasConcept C150903083 @default.
• W137668043 hasConcept C203014093 @default.
• W137668043 hasConcept C207001950 @default.
• W137668043 hasConcept C26291073 @default.
• W137668043 hasConcept C2776555147 @default.
• W137668043 hasConcept C2778689377 @default.
• W137668043 hasConcept C2779548794 @default.
• W137668043 hasConcept C2779629538 @default.
• W137668043 hasConcept C2780402444 @default.
• W137668043 hasConcept C2781092759 @default.
• W137668043 hasConcept C2909039274 @default.
• W137668043 hasConcept C41008148 @default.
• W137668043 hasConcept C71924100 @default.
• W137668043 hasConcept C71928629 @default.
• W137668043 hasConcept C86803240 @default.
• W137668043 hasConcept C89423630 @default.
• W137668043 hasConcept C98274493 @default.
• W137668043 hasConcept C98319499 @default.
• W137668043 hasConceptScore W137668043C136764020 @default.
• W137668043 hasConceptScore W137668043C150903083 @default.
• W137668043 hasConceptScore W137668043C203014093 @default.
• W137668043 hasConceptScore W137668043C207001950 @default.
• W137668043 hasConceptScore W137668043C26291073 @default.
• W137668043 hasConceptScore W137668043C2776555147 @default.
• W137668043 hasConceptScore W137668043C2778689377 @default.
• W137668043 hasConceptScore W137668043C2779548794 @default.
• W137668043 hasConceptScore W137668043C2779629538 @default.
• W137668043 hasConceptScore W137668043C2780402444 @default.
• W137668043 hasConceptScore W137668043C2781092759 @default.
• W137668043 hasConceptScore W137668043C2909039274 @default.
• W137668043 hasConceptScore W137668043C41008148 @default.
• W137668043 hasConceptScore W137668043C71924100 @default.
• W137668043 hasConceptScore W137668043C71928629 @default.
• W137668043 hasConceptScore W137668043C86803240 @default.
• W137668043 hasConceptScore W137668043C89423630 @default.
• W137668043 hasConceptScore W137668043C98274493 @default.
• W137668043 hasConceptScore W137668043C98319499 @default.
• W137668043 hasLocation W1376680431 @default.
• W137668043 hasLocation W1376680432 @default.
• W137668043 hasOpenAccess W137668043 @default.
• W137668043 hasPrimaryLocation W1376680431 @default.
• W137668043 hasRelatedWork W2026378453 @default.
• W137668043 hasRelatedWork W2046209746 @default.
• W137668043 hasRelatedWork W2072809427 @default.
• W137668043 hasRelatedWork W2084458610 @default.

• next